These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 21912473)

  • 21. Concomitant functional dyspepsia and irritable bowel syndrome decrease health-related quality of life in gastroesophageal reflux disease.
    De Vries DR; Van Herwaarden MA; Baron A; Smout AJ; Samsom M
    Scand J Gastroenterol; 2007 Aug; 42(8):951-6. PubMed ID: 17613924
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endoscopic and symptoms analysis in Mexican patients with irritable Bowel syndrome, dyspepsia, and gastroesophageal reflux disease.
    Camacho S; Bernal F; Abdo M; Awad RA
    An Acad Bras Cienc; 2010 Dec; 82(4):953-62. PubMed ID: 21152770
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence and clinical characteristics of refractoriness to optimal proton pump inhibitor therapy in non-erosive reflux disease.
    Ribolsi M; Cicala M; Zentilin P; Neri M; Mauro A; Efthymakis K; Petitti T; Savarino V; Penagini R
    Aliment Pharmacol Ther; 2018 Nov; 48(10):1074-1081. PubMed ID: 30294924
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative study of omeprazole, lansoprazole, pantoprazole and esomeprazole for symptom relief in patients with reflux esophagitis.
    Zheng RN
    World J Gastroenterol; 2009 Feb; 15(8):990-5. PubMed ID: 19248200
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gastroesophageal reflux disease (GERD) and irritable bowel syndrome (IBS)--is it one disease or an overlap of two disorders?
    Gasiorowska A; Poh CH; Fass R
    Dig Dis Sci; 2009 Sep; 54(9):1829-34. PubMed ID: 19082721
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Meta-analysis of the efficacy and safety of pantoprazole in the treatment and symptom relief of patients with gastroesophageal reflux disease - PAN-STAR.
    Dabrowski A; Štabuc B; Lazebnik L
    Prz Gastroenterol; 2018; 13(1):6-15. PubMed ID: 29657605
    [TBL] [Abstract][Full Text] [Related]  

  • 27. It is possible to classify non-erosive reflux disease (NERD) patients into endoscopically normal groups and minimal change groups by subjective symptoms and responsiveness to rabeprazole -- a report from a study with Japanese patients.
    Kusano M; Shirai N; Yamaguchi K; Hongo M; Chiba T; Kinoshita Y;
    Dig Dis Sci; 2008 Dec; 53(12):3082-94. PubMed ID: 18465242
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Asthma and gastroesophageal reflux disease: effect of long-term pantoprazole therapy.
    Calabrese C; Fabbri A; Areni A; Scialpi C; Zahlane D; Di Febo G
    World J Gastroenterol; 2005 Dec; 11(48):7657-60. PubMed ID: 16437694
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Non-erosive reflux disease (NERD), symptomatic and asymptomatic erosive reflux disease (ERD): from hypersensitive to hyposensitive esophagus.
    Hartono JL; Qua CS; Goh KL
    Dig Dis Sci; 2011 Jan; 56(1):90-6. PubMed ID: 20467897
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Investigation of pretreatment prediction of proton pump inhibitor (PPI)-resistant patients with gastroesophageal reflux disease and the dose escalation challenge of PPIs-TORNADO study: a multicenter prospective study by the Acid-Related Symptom Research Group in Japan.
    Furuta T; Shimatani T; Sugimoto M; Ishihara S; Fujiwara Y; Kusano M; Koike T; Hongo M; Chiba T; Kinoshita Y;
    J Gastroenterol; 2011 Nov; 46(11):1273-83. PubMed ID: 21861141
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of coexisting irritable bowel syndrome and non-erosive reflux disease on postprandial abdominal fullness and sleep disorders in functional dyspepsia.
    Futagami S; Yamawaki H; Shimpuku M; Izumi N; Wakabayashi T; Kodaka Y; Nagoya H; Shindo T; Kawagoe T; Sakamoto C
    J Nippon Med Sch; 2013; 80(5):362-70. PubMed ID: 24189354
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gastroesophageal reflux disease and irritable bowel syndrome: a common overlap syndrome.
    Dickman R; Feroze H; Fass R
    Curr Gastroenterol Rep; 2006 Aug; 8(4):261-5. PubMed ID: 16886306
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Symptom overlaps between functional heartburn, functional dyspepsia, and irritable bowel syndrome].
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2014 May; 45(3):489-92. PubMed ID: 24941825
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative clinical trial of S-pantoprazole versus racemic pantoprazole in the treatment of gastro-esophageal reflux disease.
    Pai VG; Pai NV; Thacker HP; Shinde JK; Mandora VP; Erram SS
    World J Gastroenterol; 2006 Oct; 12(37):6017-20. PubMed ID: 17009401
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Symptoms and quality of life in underweight gastroesophageal reflux disease patients and therapeutic responses to proton pump inhibitors.
    Hongo M; Miwa H; Kusano M;
    J Gastroenterol Hepatol; 2012 May; 27(5):913-8. PubMed ID: 22142515
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endoscopic grading of gastroesophageal flap valve helps predict proton pump inhibitor response in patients with gastroesophageal reflux disease.
    Cheong JH; Kim GH; Lee BE; Choi MK; Moon JY; Ryu DY; Kim DU; Song GA
    Scand J Gastroenterol; 2011 Jul; 46(7-8):789-96. PubMed ID: 21615222
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of rabeprazole on heartburn symptom resolution in patients with non-erosive and erosive gastro-oesophageal reflux disease: a multicenter study from Japan.
    Miwa H; Sasaki M; Furuta T; Koike T; Habu Y; Ito M; Fujiwara Y; Wada T; Nagahara A; Hongo M; Chiba T; Kinoshita Y;
    Aliment Pharmacol Ther; 2007 Jul; 26(1):69-77. PubMed ID: 17555423
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Esophageal cell proliferation in gastroesophageal reflux disease: clinical-morphological data before and after pantoprazole.
    Calabrese C; Treré D; Liguori G; Gabusi V; Vici M; Cenacchi G; Derenzini M; Di Febo G
    World J Gastroenterol; 2009 Feb; 15(8):936-41. PubMed ID: 19248192
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical outcome of laparoscopic antireflux surgery for patients with irritable bowel syndrome.
    Raftopoulos Y; Papasavas P; Landreneau R; Hayetian F; Santucci T; Gagné D; Caushaj P; Keenan R
    Surg Endosc; 2004 Apr; 18(4):655-9. PubMed ID: 15026924
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of Overlapping Functional Gastrointestinal Disorders on the Presentation and Quality of Life of Patients with Erosive Esophagitis and Nonerosive Reflux Disease.
    Lee SW; Chang CS; Lien HC; Peng YC; Wu CY; Yeh HZ
    Med Princ Pract; 2015; 24(5):491-5. PubMed ID: 26137901
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.